[Asia Economy Reporter Jang Hyowon] In South Korea, reports of suspected adverse reactions following COVID-19 vaccination increased by 197 cases on the 24th. Two additional death reports were also made, but no causal relationship between vaccination and death has been confirmed.


The COVID-19 Vaccination Response Promotion Team (Promotion Team) announced on the 25th at midnight that there were 197 new cases reported of adverse reactions after vaccination.


Among these, death reports increased by 2, both cases involving recipients of the Pfizer vaccine. Causality between vaccination and death has not yet been confirmed.

[Image source=Yonhap News]

[Image source=Yonhap News]

View original image

Five additional suspected cases of anaphylaxis, a severe systemic allergic reaction, were also reported. Four cases involved AstraZeneca vaccine recipients, and one involved a Pfizer vaccine recipient. The health authorities will evaluate the causal relationship with vaccination in the future.


No additional severe suspected cases such as convulsions or ICU admissions were reported. The remaining 190 cases were mild symptoms commonly occurring after vaccination, such as muscle pain, headache, fever, chills, and nausea.


Since vaccinations began domestically on February 26, the cumulative number of suspected adverse reaction reports has reached 13,529. As of midnight on this day, this represents about 0.57% of the total 2,365,177 first and second dose recipients in the country.



Among these, 12,050 cases (89.1% of total reports) were related to the AstraZeneca vaccine. Reports related to the Pfizer vaccine total 1,479 cases (10.9%) so far. The adverse reaction reporting rate relative to the number of vaccine recipients is 0.92% for AstraZeneca and 0.14% for Pfizer.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing